A Prognostic System Applicable to Patients with Resectable Liver Metastasis from Colorectal Carcinoma Staged by Positron Emission Tomography with [18F]Fluoro-2-Deoxy-D-Glucose: Role of Primary Tumor Variables

Journal of the American College of Surgeons

Volumn 206, Issue 5, 2008, Pages 857-868

  Tan, Marcus C B ^a   Castaldo, Eric T ^d   Gao, Feng ^b   Chari, Ravi S ^d   Linehan, David C ^a,b   Wright, J Kelly ^d   Hawkins, William G ^a,b   Siegel, Barry A ^b,c   Delbeke, Dominique ^d   Pinson, C Wright ^d   Strasberg, Steven M ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b USA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; TIME SERIES ANALYSIS; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; VILOXAZINE;

EID: 43049084010     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2007.12.023     Document Type: Article

References (54)

1. Fernandez F.G., Drebin J.A., Linehan D.C., et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240 (2004) 438-447
2. Fong Y., Fortner J., Sun R.L., et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-318
3. Jaeck D., Bachellier P., Guiguet M., et al. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg 84 (1997) 977-980
4. Scheele J., Stangl R., and Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77 (1990) 1241-1246
5. Stangl R., Altendorf-Hofmann A., Charnley R.M., and Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 343 (1994) 1405-1410
6. Ambiru S., Miyazaki M., Isono T., et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 42 (1999) 632-639
7. Choti M.A., Sitzmann J.V., Tiburi M., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235 (2002) 759-766
8. Imamura H., Matsuyama Y., Shimada R., et al. A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol 96 (2001) 3178-3184
9. Iwatsuki S., Dvorchik I., Madariaga J.R., et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 189 (1999) 291-299
10. Minagawa M., Yamamoto J., Kosuge T., et al. Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation. Arch Surg 142 (2007) 269-276
11. Nordlinger B., Guiguet M., Vaillant J.C., et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77 (1996) 1254-1262
12. Sasaki A., Iwashita Y., Shibata K., et al. Analysis of preoperative prognostic factors for long-term survival after hepatic resection of liver metastasis of colorectal carcinoma. J Gastrointest Surg 9 (2005) 374-380
13. Scheele J., Stang R., Altendorf-Hofmann A., and Paul M. Resection of colorectal liver metastases. World J Surg 19 (1995) 59-71
14. Schindl M., Wigmore S.J., Currie E.J., et al. Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg 140 (2005) 183-189
15. Tanaka K., Shimada H., Ueda M., et al. Long-term characteristics of 5-year survivors after liver resection for colorectal metastases. Ann Surg Oncol 14 (2007) 1336-1346
16. Zakaria S., Donohue J.H., Que F.G., et al. Hepatic resection for colorectal metastases: value for risk scoring systems?. Ann Surg 246 (2007) 183-191
17. Younes R.N., Rogatko A., and Brennan M.F. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg 214 (1991) 107-113
18. Fortner J.G., Silva J.S., Golbey R.B., et al. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 199 (1984) 306-316
19. Altendorf-Hofmann A., and Scheele J. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am 12 (2003) 165-192
20. Strasberg S.M., Dehdashti F., Siegel B.A., et al. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Ann Surg 233 (2001) 293-299
21. Vitola J.V., Delbeke D., Sandler M.P., et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 171 (1996) 21-26
22. Yang Y.Y., Fleshman J.W., and Strasberg S.M. Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases. J Gastrointest Surg 11 (2007) 929-944
23. Bipat S., van Leeuwen M.S., Comans E.F., et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology 237 (2005) 123-131
24. Huebner R.H., Park K.C., Shepherd J.E., et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 41 (2000) 1177-1189
25. Kantorova I., Lipska L., Belohlavek O., et al. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med 44 (2003) 1784-1788
26. Kinkel K., Lu Y., Both M., et al. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224 (2002) 748-756
27. Wiering B., Krabbe P.F., Jager G.J., et al. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer 104 (2005) 2658-2670
28. Chapman W.C., Hoff P.M., and Strasberg S.M. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement by Charnsangavej et al. Ann Surg Oncol 13 (2006) 1269-1270
29. Charnsangavej C., Clary B., Fong Y., et al. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13 (2006) 1261-1268
30. th ed. (2002), Lippincott-Raven, Philadelphia 113-124
31. Anderson C.D., Rice M.H., Pinson C.W., et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8 (2004) 90-97
32. Tan M.C., Linehan D.C., Hawkins W.G., et al. Chemotherapy-induced normalization of FDG uptake by colorectal liver metastases does not usually indicate complete pathologic response. J Gastrointest Surg 11 (2007) 1112-1119
33. The terminology committee of the IHPBA. The Brisbane 2000 terminology of hepatic anatomy and resections. HPB 2 (2000) 333-339
34. Harrell Jr. F.E., Lee K.L., and Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361-387
35. Little R.J.A., and Rubin D.B. Statistical analysis with missing data (1987), John Wiley & Sons, New York
36. Neal C.P., Garcea G., Doucas H., et al. Molecular prognostic markers in resectable colorectal liver metastases: a systematic review. Eur J Cancer 42 (2006) 1728-1743
37. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery 103 (1988) 278-288
38. Adson M.A., van Heerden J.A., Adson M.H., et al. Resection of hepatic metastases from colorectal cancer. Arch Surg 119 (1984) 647-651
39. Bramhall S.R., Gur U., Coldham C., et al. Liver resection for colorectal metastases. Ann R Coll Surg Engl 85 (2003) 334-339
40. Doci R., Gennari L., Bignami P., et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 78 (1991) 797-801
41. Ekberg H., Tranberg K.G., Andersson R., et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73 (1986) 727-731
42. Fegiz G., Ramacciato G., D'Angelo F., et al. Patient selection and factors affecting results following resection for hepatic metastases from colorectal carcinoma. Int Surg 76 (1991) 58-63
43. Gayowski T.J., Iwatsuki S., Madariaga J.R., et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116 (1994) 703-710
44. Gazzaniga G.M., Cogolo L.A., Ciferri E., and Pestarino C. Liver surgery for metastases: clinical results. J Surg Oncol Suppl 2 (1991) 59-62
45. Jamison R.L., Donohue J.H., Nagorney D.M., et al. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 132 (1997) 505-510
46. Jenkins L.T., Millikan K.W., Bines S.D., et al. Hepatic resection for metastatic colorectal cancer. Am Surg 63 (1997) 605-610
47. Kato T., Yasui K., Hirai T., et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 46 (2003) S22-S31
48. Liu C.L., Fan S.T., Lo C.M., et al. Hepatic resection for colorectal liver metastases: prospective study. Hong Kong Med J 8 (2002) 329-333
49. Rees M., Plant G., and Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 84 (1997) 1136-1140
50. Schlag P., Hohenberger P., and Herfarth C. Resection of liver metastases in colorectal cancer-competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 16 (1990) 360-365
51. Stehlin Jr. J.S., de Ipolyi P.D., Greeff P.J., et al. Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients. Ann Surg 208 (1988) 23-35
52. Yamaguchi A., Kurosaka Y., Kanno M., et al. Analysis of hepatic recurrence of colorectal cancer after resection of hepatic metastases. Int Surg 78 (1993) 16-19
53. Cohade C., Osman M., Leal J., and Wahl R.L. Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 44 (2003) 1797-1803
54. Kim J.H., Czernin J., Allen-Auerbach M.S., et al. Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. J Nucl Med 46 (2005) 587-595